Published Date: 17 Feb 2023
A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...
Read Full NewsConaghan discussed the potential of LEVI-04 for knee osteoarthritis at ACR 2025.
The adaptive PRImus-AD phase 2a trial will evaluate the safety and efficacy of PRI-002, a novel investigational agent, in patients with mild cognitive impairment or mild Alzheimer disease.
Treatment with etalanetug reduced cerebrospinal fluid eMTBR-tau243 by 62% and plasma eMTBR-tau243 by 78% at 3 months in patients with dominantly inherited Alzheimer disease.
A recent study reveals that Araclon's ABvac40 vaccine may slow cortical perfusion decline in patients with Alzheimer disease, suggesting potential cognitive benefits.
In her SDPA Fall Dermatology Conference interview, Holzem highlights key warning signs for a variety of dermatologic conditions requiring hospital admission.
Firsekibart Beats Colchicine as Gout Flare Prophylaxis When Initiating ULT
Deep Capillary Plexus Microaneurysms A Sign of CKD in Diabetic Retinopathy
1.
Journal Club: A well-accepted and safe method for soft tissue sarcoma biopsy.
2.
Analysis of 2021 data shows new cancer diagnoses did not rebound as expected following pandemic
3.
Alkem introduces cetuximab under the trade name Cetuxa in India.
4.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
5.
Prostate cancer screening seems to be improved by PSA, biomarker testing, and MRI combined.
1.
Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being
2.
Understanding Histiocytosis: Symptoms, Causes, and Treatment Options
3.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
4.
Tertiary Lymphoid Structures in Cancer: Advancing Therapeutic Implications
5.
Unlocking the Potential of Lymphocytes: Exploring the Role of These Immune System Cells
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Oropharyngeal Cancer in Relation to HPV Status
2.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation